Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53
Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53
复制标题
白杨素与顺铂联合上调p53促进Hep G2细胞凋亡
DOI:
10.1016/j.cbi.2015.03.003
复制
发表时间:
2015-05-05
影响因子:
5.1
通讯作者:
Zou, Fei
中科院分区:
文献类型:
--
作者:
Li, Xin;Huang, Jun-Ming;Zou, Fei
Cisplatin is a chemotherapy drug commonly used for the treatment of human cancers, however, drug resistance poses a major challenge to clinical application of cisplatin in cancer therapy. Recent studies have shown that chrysin, a natural fiavonoid widely found in various plants and foods, demonstrated effective anti-cancer activity. In the present study, we found that the combination chrysin and cisplatin significantly enhanced the apoptosis of Hep G2 cancer cells. Combination of chrysin and cisplatin increased the phosphorylation and accumulation of p53 through activating ERK1/2 in Hep G2 cells, which led to the overexpression of the pro-apoptotic proteins Bax and DR5 and the inhibition of the antiapoptotic protein BcI-2. In addition, combination of chrysin and cisplatin promoted both extrinsic apoptosis by activating caspase-8 and intrinsic apoptosis by increasing the release of cytochrome c and activating caspase-9 in Hep G2 cells. Our results suggest that combination of chrysin and cisplatin is a promising strategy for chemotherapy of human cancers that are resistant to cisplatin. (C) 2015 Published by Elsevier Ireland Ltd.